The GALECTIN THERAPEUTICS brand, founded in 2013 (United States), from 2 sister brands and 2214 competing brands. GALECTIN THERAPEUTICS is a brand of Galectin Therapeutics, listed on the stock exchange of New York. GALECTIN THERAPEUTICS belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Galectin Therapeutics
over 5 years*
USD 2.53